🇺🇸 FDA

Drug profile · INN

lutetium lu 177 dotatate

LUTATHERA

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

lutetium lu 177 dotatate (LUTATHERA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN lutetium lu 177 dotatate
Brand LUTATHERA
Route INTRAVENOUS
Formulation SOLUTION

Frequently asked questions

What is lutetium lu 177 dotatate?

lutetium lu 177 dotatate (LUTATHERA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for lutetium lu 177 dotatate?

LUTATHERA is a marketed brand name for lutetium lu 177 dotatate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of lutetium lu 177 dotatate?

lutetium lu 177 dotatate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.